SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ)
$7.73 -0.2 (-2.5221%)
Analysed SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) News Sources
European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday Trading
21-04-2026
yahoo.com
Silence Therapeutics (SLN) Soars 19.0%: Is Further Upside Left in the Stock?
16-04-2026
yahoo.com
European Equities Traded in the US as ADRs Rise in Tuesday Trading
14-04-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading
13-04-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
10-04-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
09-04-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading
07-04-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading
06-04-2026
yahoo.com
We Think Silence Therapeutics (NASDAQ:SLN) Needs To Drive Business Growth Carefully
01-04-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
27-03-2026
yahoo.com
What is the current price of SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ)?
The current price of SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) is $7.73.
SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) absolute price change since previous trading day?
The absolute price change of SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) since the previous trading day is $-0.2.
SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) percentage price change since previous trading day?
The percentage price change of SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) since the previous trading day is -2.5221%.
What is the most recent average sentiment score for SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ)?
The most recent average sentiment score for SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ)?
The most recent sentiment for SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) is .
SEC-8K** Filing Available For SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.